Back to Directory

Justine Beck

Email

Justine.beck@nih.gov

Phone

301-761-5288

Institution

PAB, DAIDS, NIAID, NIH

Address

Pharmaceutical Affairs Branch
5601 Fishers Lane
MSC 9829
Rockville, MD 20852

Request an Update

Affiliated Studies

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2042: Tatelo Plus

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

Closed to Accrual

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Follow Up

Show All